Sphingosine kinase 1 (SPHK1) facilitates cell survival, proliferation, transformation, and angiogenesis, while miR-506 targets SPHK1 to reduce its expression at the cellular, mRNA, and protein levels, inhibiting liver cancer angiogenesis (80). This evidence concerns the gene SPHK1 and liver cancer.